-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Innovation Pharmaceuticals Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2023.
- Innovation Pharmaceuticals Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$866K, a 38.7% increase year-over-year.
- Innovation Pharmaceuticals Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$2.56M, a 46.8% increase year-over-year.
- Innovation Pharmaceuticals Inc. annual Operating Income (Loss) for 2023 was -$3.11M, a 55.1% increase from 2022.
- Innovation Pharmaceuticals Inc. annual Operating Income (Loss) for 2022 was -$6.92M, a 23.2% increase from 2021.
- Innovation Pharmaceuticals Inc. annual Operating Income (Loss) for 2021 was -$9.02M, a 94.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)